Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Enasidenib is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2 (IDH2) gene, determined by an FDA-approved IDH2 companion diagnostic test
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Enasidenib market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Enasidenib market. Detailed analysis of key players, along with key growth strategies adopted by Enasidenib industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Celgene Corporation
By Type:
50mg
100mg
By End-User:
Hospital
Pharmacy
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Enasidenib Market
-
1.3 Market Segment by Type
-
1.3.1 USA Enasidenib Market Size and Growth Rate of 50mg from 2016 to 2027
-
1.3.2 USA Enasidenib Market Size and Growth Rate of 100mg from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Enasidenib Market Size and Growth Rate of Hospital from 2016 to 2027
-
1.4.2 USA Enasidenib Market Size and Growth Rate of Pharmacy from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Enasidenib Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Enasidenib Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Enasidenib Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Enasidenib Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Enasidenib Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Enasidenib by Major Types
-
3.4.1 Market Size and Growth Rate of 50mg
-
3.4.2 Market Size and Growth Rate of 100mg
4 Segmentation of Enasidenib Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Enasidenib by Major End-Users
-
4.4.1 Market Size and Growth Rate of Enasidenib in Hospital
-
4.4.2 Market Size and Growth Rate of Enasidenib in Pharmacy
5 Market Analysis by Regions
-
5.1 USA Enasidenib Production Analysis by Regions
-
5.2 USA Enasidenib Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Enasidenib Landscape Analysis
-
6.1 West USA Enasidenib Landscape Analysis by Major Types
-
6.2 West USA Enasidenib Landscape Analysis by Major End-Users
7 South USA Enasidenib Landscape Analysis
-
7.1 South USA Enasidenib Landscape Analysis by Major Types
-
7.2 South USA Enasidenib Landscape Analysis by Major End-Users
8 Middle West USA Enasidenib Landscape Analysis
-
8.1 Middle West USA Enasidenib Landscape Analysis by Major Types
-
8.2 Middle West USA Enasidenib Landscape Analysis by Major End-Users
9 Northeast USA Enasidenib Landscape Analysis
-
9.1 Northeast USA Enasidenib Landscape Analysis by Major Types
-
9.2 Northeast USA Enasidenib Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Celgene Corporation
-
10.1.1 Celgene Corporation Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Enasidenib Market Size and Growth Rate of 50mg from 2016 to 2027
-
Figure USA Enasidenib Market Size and Growth Rate of 100mg from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Enasidenib Market Size and Growth Rate of Hospital from 2016 to 2027
-
Figure USA Enasidenib Market Size and Growth Rate of Pharmacy from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Enasidenib Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Enasidenib Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Enasidenib Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Enasidenib Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Enasidenib Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Enasidenib
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Enasidenib by Different Types from 2016 to 2027
-
Table Consumption Share of Enasidenib by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of 50mg
-
Figure Market Size and Growth Rate of 100mg
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Enasidenib by Different End-Users from 2016 to 2027
-
Table Consumption Share of Enasidenib by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospital
-
Figure Market Size and Growth Rate of Pharmacy
-
Table USA Enasidenib Production by Regions
-
Table USA Enasidenib Production Share by Regions
-
Figure USA Enasidenib Production Share by Regions in 2016
-
Figure USA Enasidenib Production Share by Regions in 2021
-
Figure USA Enasidenib Production Share by Regions in 2027
-
Table USA Enasidenib Consumption by Regions
-
Table USA Enasidenib Consumption Share by Regions
-
Figure USA Enasidenib Consumption Share by Regions in 2016
-
Figure USA Enasidenib Consumption Share by Regions in 2021
-
Figure USA Enasidenib Consumption Share by Regions in 2027
-
Table West USA Enasidenib Consumption by Types from 2016 to 2027
-
Table West USA Enasidenib Consumption Share by Types from 2016 to 2027
-
Figure West USA Enasidenib Consumption Share by Types in 2016
-
Figure West USA Enasidenib Consumption Share by Types in 2021
-
Figure West USA Enasidenib Consumption Share by Types in 2027
-
Table West USA Enasidenib Consumption by End-Users from 2016 to 2027
-
Table West USA Enasidenib Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Enasidenib Consumption Share by End-Users in 2016
-
Figure West USA Enasidenib Consumption Share by End-Users in 2021
-
Figure West USA Enasidenib Consumption Share by End-Users in 2027
-
Table South USA Enasidenib Consumption by Types from 2016 to 2027
-
Table South USA Enasidenib Consumption Share by Types from 2016 to 2027
-
Figure South USA Enasidenib Consumption Share by Types in 2016
-
Figure South USA Enasidenib Consumption Share by Types in 2021
-
Figure South USA Enasidenib Consumption Share by Types in 2027
-
Table South USA Enasidenib Consumption by End-Users from 2016 to 2027
-
Table South USA Enasidenib Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Enasidenib Consumption Share by End-Users in 2016
-
Figure South USA Enasidenib Consumption Share by End-Users in 2021
-
Figure South USA Enasidenib Consumption Share by End-Users in 2027
-
Table Middle West USA Enasidenib Consumption by Types from 2016 to 2027
-
Table Middle West USA Enasidenib Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Enasidenib Consumption Share by Types in 2016
-
Figure Middle West USA Enasidenib Consumption Share by Types in 2021
-
Figure Middle West USA Enasidenib Consumption Share by Types in 2027
-
Table Middle West USA Enasidenib Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Enasidenib Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Enasidenib Consumption Share by End-Users in 2016
-
Figure Middle West USA Enasidenib Consumption Share by End-Users in 2021
-
Figure Middle West USA Enasidenib Consumption Share by End-Users in 2027
-
Table Northeast USA Enasidenib Consumption by Types from 2016 to 2027
-
Table Northeast USA Enasidenib Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Enasidenib Consumption Share by Types in 2016
-
Figure Northeast USA Enasidenib Consumption Share by Types in 2021
-
Figure Northeast USA Enasidenib Consumption Share by Types in 2027
-
Table Northeast USA Enasidenib Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Enasidenib Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Enasidenib Consumption Share by End-Users in 2016
-
Figure Northeast USA Enasidenib Consumption Share by End-Users in 2021
-
Figure Northeast USA Enasidenib Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Celgene Corporation
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celgene Corporation
-
Figure Sales and Growth Rate Analysis of Celgene Corporation
-
Figure Revenue and Market Share Analysis of Celgene Corporation
-
Table Product and Service Introduction of Celgene Corporation
-
